ROOM RATE DISCOUNT ENDS TOMORROW, MAY 16!
|
|
MEMPHIS IN JULY: 4 Courses, ABIPP and Competency Exams
|
|
JULY ABIPP EXAMS
AND COMPETENCY EXAMS
July 13 - July 14 | Memphis, TN
The
American Board of Interventional Pain Physicians
(
ABIPP
)
has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become
ABIPP
certified.
Register
May1 to May 15, 2019, fee is $2,000
May 16 to May 30, fee is total of $3,000
No registrations after May 30.
ABIPP
now offers the only competency
certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
July 13
ABIPP Part I
July 13
ABIPP Part I
July 13-14
ABIPP Part II
July 14
ABIPP Competency Exam
July 13
Combined CSM/CCPM Exam for ABIPP Path
July 13
Competency Exam in Controlled Substance Management
July 13
Competency Exam in Coding, Compliance, and
Practice Management
July 13-14
Regenerative Medicine Competency Exam
July 13-14
Endoscopic Lumbar Decompression Competency Exam
939 Ridge Lake Blvd. | Memphis, TN 38120
The cut-off date for our room block with discounted rates is on June 10, 2019 or until sold out, whichever occurs first.
|
|
House Members Divided on Response to Opioid Crisis
Republicans stress border issues, Democrats talk treatment $$
WASHINGTON -- A House Oversight Committee hearing on the opioid crisis revealed a partisan split over its main drivers and how best to address them.
A Republican member identified drug supply and border security as the main problem. "One party wants more money, more money, and more money," said Rep. James Comer (R-Ky.) at Thursday's hearing held by the
House Oversight & Reform Committee.
"Until we cut off the flow of illegal drugs coming across the border ... we're still going to have a drug problem," he continued. "If we're serious about stopping the flow of illegal drugs in the U.S., we're going to have to get serious in this Congress about securing the border."
|
|
Opinion: Give Opioid Makers a Reason to Stop Overselling, Expert Says
WASHINGTON -- Ensuring that drug companies don't have an economic incentive to push their products on patients is one of the big lessons to be learned from the tobacco industry in the wake of the opioid crisis, an expert said here Monday during an opioid litigation event.
"We know that under pressure of profits or the pressure of greed, some people became billionaires selling tobacco and some people became billionaires over-prescribing opioids. How do you change the mindset that says, 'That's a risk worth taking?' That's a place where the political calculus gets the hardest," Matthew Myers, president of the Washington-based Campaign for Tobacco-Free Kids, said during the Bipartisan Policy Center–sponsored event. "But we have to recognize that there is that pressure, and [even] under the best case, there will be people in those corporations who say, 'It's worth it for me.'"
|
|
Percentage of Prescription Drug Use in the US Population From 2015 to 2016
In 2015 to 2016, 45.8 percent of the U.S. population used
prescription drugs
within the past 30 days, according to a May data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics (NCHS).
Crescent B. Martin, M.P.H., from the NCHS in Hyattsville, Maryland, and colleagues used data from the National Health and Nutrition Examination Survey to describe prescription drug use by age, sex, and race/ethnicity in 2015 to 2016.
The researchers found that 45.8 percent of the U.S. population used prescription drugs in the past 30 days in 2015 to 2016. There was an increase in prescription drug use with age, from 18.0 percent for children aged younger than 12 years to 85.0 percent among adults aged 60 years and older. Non-Hispanic whites had the highest prescription drug use, followed by blacks, with the lowest use among non-Hispanic Asians and Hispanics. The most commonly used types of drugs included bronchodilators, central nervous system stimulants, antidepressants, and lipid-lowering drugs for ages 0 to 11, 12 to 19, 20 to 59, and 60 years and older, respectively. Compared with the preceding decade, there was a decrease in the percentage of the U.S. population that used drugs.
|
|
Fatal Overdoses Reduced With Pharmacist Dispensation of Naloxone
HealthDay News – Only state naloxone access laws (NALs) allowing direct dispensing of
naloxone
by pharmacists appear to be useful in cutting fatal overdose rates, according to a study published online May 6 in
JAMA Internal Medicine
.
Rahi Abouk, PhD, from William Paterson University in Wayne, New Jersey, and colleagues compared fatal and nonfatal overdoses in states that adopted NALs to those in states that did not adopt NALs from 2005 to 2016.
|
|
Interventional Pain Management Reports
is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine.
Interventional Pain Management Reports
is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of
Pain Physician
.
Interventional Pain Management Reports Interventional Pain Management Reports
is an open access journal, available online with free full manuscripts.
The benefits of publishing in an open access journal that has a corresponding
print edition journal are:
- Your article will have the potential to obtain more citations.
- Your article will be peer-reviewed and published faster than other journals.
- Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.
- Open Access journals are FREE to view, download and to print.
So submit today your:
- Case Reports
- Technical Reports
- Editorials
- Short Perspectives
|
|
Biologics Guidelines for LBP Tout PRP, Stem Cell Injections
Evidence exists for biologic therapy in treating low back pain, specifically with platelet-rich plasma or stem cells for disk injections, whereas the evidence is limited for lumbar facet joint, lumbar epidural and sacroiliac joint injections, according to new guidelines from the American Society of Interventional Pain Physicians.
The 74-page document in the journal Pain Physician (2019;22[1S]:S1-S74) notes that these injections have Level IV evidence, whereas there is Level III evidence for employing intradiskal injections of platelet-rich plasma (PRP) and mesenchymal stem cell injections.
|
|
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
MARLBOROUGH, Mass., May 9, 2019 /PRNewswire/ -- Boston Scientific (NYSE:
BSX
) today announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion
®
Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The procedure – primarily performed by physicians who treat chronic pain patients with therapies including spinal cord stimulation and radiofrequency ablation – is expected to reach $60 million in sales in 2019. The transaction consists of $465 million in upfront cash and additional payments contingent on commercial milestones for the next three years.
As many as six million people in the U.S. suffer from LSS, the narrowing of the spinal canal, which can cause compression of nearby nerves and result in significant low back and leg pain, disability, functional impairment and diminished quality of life.
1
|
|
Keep Bonuses Coming for New Medicare Models, Senators Told
Extending them for another 3 years isn't enough
WASHINGTON -- Extending the 5% payment bonus for participating in one of Medicare's new advanced alternative payment models (APMs) would help encourage their adoption, witnesses told the Senate Finance Committee Wednesday, although they had different ideas on how long it should be extended.
"We urge Congress to extend the APM incentive for an additional 6 years," said Barbara McAneny, MD, president of the American Medical Association (AMA).
"We recommend the bonuses be extended for an additional 3-5 years," said John Cullen, MD, president of the American Academy of Family Physicians (AAFP).
|
|
2019 MIPS Reporting? Start Now.
MIPS-eligible clinicians must report a full year of data. Don’t fall behind – keep up with NIPM-QCDR.
MIPS 2019 has brought larger payment adjustments and greater reporting requirements, including a 365-day performance period for the Quality and Cost categories. The sooner you start your MIPS reporting for 2019, the better.
Sign up today to use ASIPP’s NIPM-QCDR for MIPS.
This powerful tool makes MIPS reporting easy through the use of our new patient-reported outcomes measures for 2019, which ease the burden on providers and reduces costly EMR integration.
|
|
Pain Physician
March/April 2019 Issue Features
Systematic Review
Ian D. Coulter, PhD, Cindy Crawford, BA, Howard Vernon, DC. PhD, Eric L. Hurwitz, DC. PhD, Raheleh Khorsan, PhD, Marika Suttorp Booth, MS, and Patricia M. Herman, ND, PhD
Systematic Review
Nitika Sanger, HBSc, Meha Bhatt, MSc, Nikhita Singhal, BHSc, Katherine Ramsden, MD, Natasha Baptist-Mohseni, BSc, Balpreet Panesar, BSc, Hamnah Shahid, BASc, Alannah Hillmer, BSc, Alessia D'Elia, BSc, Candice Luo, BHSc, Victoria Rogers, BSc, Abirami Arunan, HBSc, Lola Baker-Beal, BSc, Sean Haber, BSc, Jihane Henni, BSc, Megan Puckering, BSc, Sunny Sun, BSc, Kim Ng, BSc, Stephanie Sanger, MLIS, Natalia Mouravaska, MD, M. Constantine Samaan, MD, Russell de Souza, ScD, Lehana Thabane, PhD, and Zainab Samaan, PhD
Randomized Trial
Doo-Hwan Kim, MD, Myung-Su Lee, MD, Sookyung Lee, MD, Syn-Hae Yoon, MD, Jin-Woo Shin, MD, PhD, and Seong-Soo Choi, MD, PhD
Randomized Controlled Trial
Neerja Bharti, MD, John Sujith, MD, Navneet Singla, Mch, Nidhi B. Panda, MD, and Indu Bala, MD.
|
|
Florida physician charged with manslaughter after patient dies of overdose
Federal agents arrested Marta Elena Farinas, DO, on manslaughter, drug dealing and drug trafficking charges on May 7, more than a year after one of her patients died of an accidental overdose, according to the
Miami Herald
.
In March 2018, Leigh Anne Milazzo died of an overdose of oxycodone and alprazolam at her home in Key Largo, Fla. An investigation into the 35-year-old's death revealed Dr. Farinas prescribed her 180 Oxycodone pills a month, according to the report.
Dr. Farinas allegedly prescribed large quantities of pills to Ms. Millazo and other patients. After the prescriptions were filled from different pharmacies, she would allegedly ask the patients to give her a portion of the pills. In text messages obtained by investigators, Ms. Millazzo and Dr. Farinas discuss sharing pills that Dr. Farinas prescribed.
|
|
Justice Department Files Action to Enjoin Texas Doctors From Illegally Prescribing Highly Addictive Opioids and Other Controlled Substances
Temporary Restraining Order Issued Against Doctors Prescribing Opioids with No Legitimate Medical Purpose
The Department of Justice’s Civil Division and the United States Attorney’s Office for the Northern District of Texas announced an action today to stop two Texas doctors from unlawfully prescribing powerful opioids linked to abuse and diversion. To protect the public, the United States sought and the court granted immediate relief through a temporary restraining order.
In a civil complaint unsealed today in the Northern District of Texas, the United States alleges that Cesar B. Pena Rodriguez M.D., and Leovares A. Mendez M.D., were prescribing in violation of the Controlled Substances Act. According to the complaint, the defendants issued thousands of prescriptions without apparent regard for patient harm, including prescriptions for a combination of an opioid, a short-acting benzodiazepine, and a muscle relaxer – a dangerous and frequently-abused drug cocktail known as the “trinity.” The United States Attorney’s Office worked with the Consumer Protection Branch of the Justice Department’s Civil Division in this effort.
Vermont Man Who Exploited Opioid Addictions of Young Women Convicted of Multiple Counts of Sex and Drug Trafficking
and Related Offenses
After a three-week trial, a federal jury in Burlington, Vermont, found Brian Folks, 44, guilty of 13 federal felonies arising from his operation of a violent sex and drug trafficking enterprise that sold heroin and forced young, drug-addicted women to prostitute throughout the greater Burlington area. The verdict was announced by Assistant Attorney General Eric Dreiband for the Department of Justice’s Civil Rights Division, U.S. Attorney Cristina E. Nolan for the District of Vermont, and DEA Special Agent in Charge-Boston Brian D. Boyle.
The jury deliberated for six hours yesterday before convicting Folks of all sex and drug trafficking counts. The convictions included five counts of sex trafficking by force, fraud, or coercion; one count of sex trafficking of a minor; one count of operating an unlawful prostitution business enterprise; five counts of distributing heroin; one count of possession of cocaine base with intent to distribute; and one count of conspiracy to distribute heroin and cocaine base. The jury acquitted the defendant of one count of felon in possession of a firearm.
|
|
July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL
|
|
|
|
|
|
|
